RHEUMATOLOGY ADVANCES IN PRACTICE, cilt.2, 2018 (ESCI İndekslerine Giren Dergi)
Objective. PsA is a heterogeneous disease with various subtypes of joint manifestations, which can affect the homogeneity of randomized controlled trials (RCTs). The aim of this systematic literature review was to evaluate the inclusion criteria, demographics and outcomes of RCTs to see whether the whole spectrum of PsA was represented.